Dr. Reddy's Laboratories
RDY
#2052
Rank
HK$77.05 B
Marketcap
HK$92.53
Share price
3.69%
Change (1 day)
-18.76%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2026 (TTM): HK$5.18 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are HK$3.76 Billion. In 2025 the company made an earning of HK$6.84 Billion a decrease over its 2024 earnings that were of HK$7.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$5.18 B-24.33%
2025 HK$6.84 B-2.73%
2024 HK$7.04 B7.01%
2023 HK$6.57 B32.93%
2022 HK$4.94 B26.77%
2021 HK$3.90 B31.44%
2020 HK$2.97 B54.54%
2019 HK$1.92 B-14.21%
2018 HK$2.24 B26.41%
2017 HK$1.77 B4.47%
2016 HK$1.69 B-55.7%
2015 HK$3.82 B1.83%
2014 HK$3.76 B-3.78%
2013 HK$3.90 B54.07%
2012 HK$2.53 B-16.23%
2011 HK$3.02 B56.66%
2010 HK$1.93 B-235.36%
2009 -HK$1.43 Billion-198.53%
2008 HK$1.44 B30.77%
2007 HK$1.10 B-14.61%
2006 HK$1.29 B703.63%
2005 HK$0.16 B649.45%
2004 HK$21.55 M-95.68%
2003 HK$0.49 B-14.86%
2002 HK$0.58 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$123.77 B 2,278.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$83.05 B 1,495.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.05 B 1,053.88%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
HK$78.50 B 1,408.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$17.80 B 242.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel